Abbott Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?
ABBOTT has one hundred and eleven approved drugs.
Drugs and US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 084160-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 080001-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | EUTONYL | pargyline hydrochloride | TABLET;ORAL | 013448-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | GENTAMICIN SULFATE | gentamicin sulfate | INJECTABLE;INJECTION | 062413-001 | Aug 11, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | A-HYDROCORT | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 089579-001 | Apr 11, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | A-METHAPRED | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 089574-001 | Feb 22, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-004 | Aug 7, 1987 | 5,294,615 | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-004 | Aug 7, 1987 | 5,212,176 | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | 4,251,532 | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | 5,212,176 | ⤷ Try a Trial |
Abbott | NORVIR | ritonavir | CAPSULE;ORAL | 020680-001 | Mar 1, 1996 | 5,648,497*PED | ⤷ Try a Trial |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-001 | Nov 22, 1997 | 4,746,680*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
Similar Applicant Names
Here is a list of applicants with similar names.